azauridine has been researched along with Experimental Hepatoma in 3 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anukarahanonta, T | 1 |
| Holstege, A | 3 |
| Keppler, DO | 3 |
| Giesen, EM | 1 |
| Beck, G | 1 |
| Herrmann, B | 1 |
3 other studies available for azauridine and Experimental Hepatoma
| Article | Year |
|---|---|
Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.
Topics: Animals; Aspartic Acid; Azauridine; DNA, Neoplasm; Drug Therapy, Combination; Female; Galactosamine; | 1980 |
Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells.
Topics: Animals; Azauridine; Cells, Cultured; Dexamethasone; Enzyme Induction; Galactosamine; Liver Neoplasm | 1981 |
Increased formation of nucleotide derivatives of 5-fluorouridine in hepatoma cells treated with inhibitors of pyrimidine synthesis and D-galactosamine.
Topics: Animals; Azauridine; Biological Transport; Female; Galactosamine; Kinetics; Liver Neoplasms, Experim | 1978 |